(1)
Shmela, M.; Habbassi, M. Overview in EMA and FDA Approved Novel Drugs in the Years 2020, 2021 and 2022. LJMR 2024, 18 (1), 178-192. https://doi.org/10.54361/Ljmr18-1.18.